Profile
ATLN DHR-PB TMO DHR IDXX A
Company Name Atlantic International Corp. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $207.77M $916.76B $203.95B $153.12B $51.80B $36.74B
Employees 0.30K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Michael Tenore Rainer M. Blair Marc N. Casper Rainer Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
ATLN DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
ATLN DHR-PB TMO DHR IDXX A
Last Close $2.5 $1261.26 $567.16 $220.44 $669 $144.52
High 52 $6.55 $1261.26 $606.74 $250.59 $722.94 $152.6
Low 52 $1.5 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -61.83 % 0 % -6.52 % -12.03 % -7.46 % -5.29 %
Price vs. 52 Week Low 66.67 % 0 % 45.35 % 26.23 % 85.3 % 45.55 %
Total Return
ATLN DHR-PB TMO DHR IDXX A
1 Month Return -18.57 % 0 % 5.24 % 5.44 % 5.29 % 1.83 %
3 Month Return -33.51 % 0 % 16.29 % 5.47 % 4.88 % 22.32 %
6 Month Return -3.85 % 0 % 37.64 % 12.41 % 29.13 % 27.03 %
9 Month Return 6.38 % 0 % 8.42 % 7.78 % 48.98 % 6.89 %
YTD Return -48.77 % 0 % 9.02 % -3.97 % 61.81 % 7.58 %
1 Year Return -51.92 % 0 % 11.4 % -4.51 % 60.69 % 14.98 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ATLN DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.58 % 0.32 % 0.59 % - 0.77 %
Dividend Paid and Capex Coverage Ration (TTM) 49.66 % 3.15 % 3.62 % 3.15 % 9.48 % 2.26 %
Dividend Per Share (TTM) - 1.28 % 1.72 % 1.28 % - 1 %
Payout Ratio (TTM) - 24.29 % 9.47 % 24.29 % - 21.64 %
Growth
ATLN DHR-PB TMO DHR IDXX A
Asset Growth -3.09 % 7.64 % 13.38 % 7.64 % 1.03 %
Gross Profit Growth 0.64 % 5.38 % -5.36 % 5.38 % 8.63 %
Revenue Growth 10.27 % 2.9 % 3.91 % 2.9 % 6.46 %
Revenue 3 Year -38.59 % -5.47 % 3.42 % -5.47 % 25.23 %
Revenue 5 Year 48082.01 % 10.08 % 45.65 % 10.08 % 69.09 %
Revenue 10 Year 19855.36 % 68 % 178.48 % 68 % 218.38 %
EBIT Growth -3178.97 % -7.15 % -6.71 % -7.15 % 3.47 %
Net Income Growth -788.28 % -7.31 % 6.35 % -7.31 % 5.07 %
Net Income 3 Yeari Growth Per Share -95.83 % -48.61 % 1.06 % -48.61 % 23.15 %
Net Income 5 Yeari Growth Per Share -3078.71 % -1.03 % 11.3 % -1.03 % 116.76 %
Net Income 10 Yeari Growth Per Share -3901.65 % 37.36 % 261.63 % 37.36 % 492.42 %
Operating Income Growth -532.61 % -0.91 % 5.83 % -0.91 % 2.84 %
Operating Cash Flow Growth (CFG) 34.1 % -4.07 % -9.8 % -4.07 % 2.48 %
Operating 3 Year CFG -77.38 % -22.79 % -10.96 % -22.79 % 27.03 %
Operating 5 Year CFG -119.1 % 3.19 % -0.67 % 3.19 % 111.28 %
Operating 10 Year CFG -17.91 % 66.57 % 194.29 % 66.57 % 378.1 %
EPS Growth -513.33 % -4.88 % 7.18 % -4.88 % 5.9 %
EPS Diluted Growth -513.33 % -4.73 % 7.32 % -4.73 % 6.06 %
Book Value Per Share 78.9 % 9.57 % 9.5 % 9.57 % 8.24 %
Share Holder 3 Year Equity Growth Per Share -186.61 % 7.54 % 26.63 % 7.54 % 138.87 %
Share Holder 5 Year Equity Growth Per Share -146.51 % 31.9 % 63.03 % 31.9 % 838.67 %
Share Holder 10 Year Equity Growth Per Share -3112.6 % 118.87 % 165.29 % 118.87 % 1547.69 %
Dividend Per Share Growth - 18.15 % 10.83 % 18.15 % -
Dividend 3 Year Growth Per Share - 10.04 % 45.73 % 10.04 % -
Dividend 5 Year Growth Per Share - 42.54 % 98.76 % 42.54 % -
Dividend 10 Year Growth Per Share - 144.73 % 180.3 % 144.73 % -
Debt Growth -42 % 7.42 % 20.17 % 7.42 % -7.53 %
Free Cash Flow Growth 33.83 % -0.68 % -13.4 % -0.68 % 3.26 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2025 31 Dec 2025 31 Dec 2024
Profitability
ATLN DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 10.85 % 60.93 % 39.46 % 60.93 % 61.8 % 52.43 %
Return on Assets TTM -91.54 % 4.33 % 6.09 % 4.33 % 31.62 % 10.24 %
Return on Equity TTM 606.38 % 6.99 % 13.14 % 6.99 % 69.78 % 20.62 %
Return on Capital Employed TTM -62.86 % 6.7 % 8.41 % 6.7 % 61.76 % 14.25 %
Net Income Per EBT TTM 133.17 % 85.38 % 92.39 % 85.38 % 80.01 % 90.8 %
EBT Per Ebit TTM 231.6 % 82.4 % 90.83 % 82.4 % 97.36 % 97.03 %
EBIT Per Revenue TTM -7.35 % 20.91 % 17.96 % 20.91 % 31.6 % 21.29 %
Cash Flow To Debt Ratio TTM 4.38 % 34.84 % 19.85 % 34.84 % 139.39 % 46.48 %
Receivables Turnover TTM 7.44 6.28 5.01 6.28 7.79 4.67
Payables Turnover TTM 74.94 5.2 - 5.2 14.89 5.8
Inventory Turnover TTM - 3.86 4.97 3.86 4.35 3.22
Fixed Asset Turnover TTM 18515.08 % 444.19 % 421.73 % 444.19 % 575.84 % 343.45 %
Asset Turnover TTM 403.95 % 29.44 % 40.38 % 29.44 % 128.44 % 54.59 %
Operating Cash Flow Per Share TTM 0.06 9.07 20.79 9.07 14.75 5.51
Free Cash Flow Per Share TTM 0.06 7.44 16.74 7.44 13.2 4.07
Cash Per Share TTM 0.15 % 652.48 % 2687.5 % 652.48 % 224.82 % 632.16 %
Operating Cash Flow Sales Ratio TTM 0.75 % 26.12 % 17.55 % 26.12 % 27.46 % 22.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 97.99 % 81.98 % 80.49 % 81.98 % 89.45 % 73.89 %
Cash Flow Coverage Ratios TTM 4.38 % 34.84 % 19.85 % 34.84 % 139.39 % 46.48 %
Price To Free Cash Flows Ratio TTM 63.19 29.56 32.41 29.11 49 31.89
Price To Operating Cash Flows Ratio TTM 57.71 24.25 26.11 23.88 43.97 23.52
Price Cash Flow Ratio TTM 57.71 24.25 26.11 23.88 43.97 23.52
Income Statement (TTM)
ATLN DHR-PB TMO DHR IDXX A
Revenue $0.44B $24.57B $44.56B $24.57B $4.3B $6.95B
Gross Profit $0.05B $14.97B $16.78B $14.97B $2.66B $3.64B
Gross Profit Ratio 10.66% 60.93% 37.66% 60.93% 61.8% 52.43%
EBITDA $-0.11B $6.95B $10.89B $6.95B $1.47B $1.84B
Net Income $-0.14B $3.61B $6.74B $3.61B $1.06B $1.3B
EPS Diluted -3.68 5.04 17.74 5.04 13.08 4.57
Balance Sheet (MRQ)
ATLN DHR-PB TMO DHR IDXX A
Long Term Debt $0.04B $18.42B $35.85B $18.42B $0.37B $3.05B
Total Liabilities $0.13B $30.93B $56.81B $30.93B $1.75B $5.99B
Total Equity $-0.01B $52.54B $53.54B $52.54B $1.61B $6.74B
Total Investments $0B $0B $0.25B $0B $0B $0.13B
Total Debt $0.08B $18.42B $39.39B $18.42B $0.85B $3.35B
Total Assets $0.12B $83.46B $110.34B $83.46B $3.35B $12.73B
Cash Flow Statement (TTM)
ATLN DHR-PB TMO DHR IDXX A
Net Income $-0.14B $3.61B $6.72B $3.61B $1.06B $0.43B
Inventory $0B $-0.06B $0B $-0.06B $0B $0.05B
Dividends Paid $0B $-0.88B $-0.64B $-0.88B $0B $-0.28B
Operating Cash Flow $-0.01B $6.42B $7.82B $6.42B $1.18B $1.56B
Capital Expenditure $-0B $-1.16B $-1.53B $-1.16B $-0.12B $-0.41B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 128.9
ACRS Aclaris Therapeutics, Inc. 3.39
ADVB Advanced Biomed Inc. Common Stock 0.247
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 5.62
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 10.35
BIAF bioAffinity Technologies, Inc. 0.993
BIAFW bioAffinity Technologies, Inc. 0.25
BIOC Biocept, Inc. 0.4349
BLLN BillionToOne, Inc. 85.74
BNGO Bionano Genomics, Inc. 1.14
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 28.88
CDNA CareDx, Inc 19.72
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 1.68
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 165.98
ETFs With Exposure to ATLN
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 341.47
IWN iShares Russell 2000 Value ETF 0 200.55
IWO iShares Russell 2000 Growth ETF 0 339.07
VXF Vanguard Extended Market Index Fund 0.00023 218.1
HDG ProShares Hedge Replication ETF 0.0000741214 52.7979
UWM ProShares Ultra Russell2000 0.000393961 53.9
IWC iShares Micro-Cap ETF 0 168.25
URTY ProShares UltraPro Russell2000 0.000303425 64.75
VTWV Vanguard Russell 2000 Value Index Fund 0.00079 176.822
VTWG Vanguard Russell 2000 Growth Index Fund 0.00082 247.625
VTWO Vanguard Russell 2000 Index Fund 0.00024 107.11
VUN.TO Vanguard U.S. Total Market Index ETF 0 126.01
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0 118.61
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00003 52.53
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00003 52.52
VBINX Vanguard Balanced Index Fund Investor Shares 0.00003 52.53
VGRO.TO Vanguard Growth ETF Portfolio 0 44.38
VEQT.TO Vanguard All-Equity ETF Portfolio 0 55.86
VBAL.TO Vanguard Balanced ETF Portfolio 0 37.88
VCNS.TO Vanguard Conservative ETF Portfolio 0 32.13
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.34
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.99
VTSAX Vanguard Total Stock Market Index Fund 0 166.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00023 165.55
VITSX Vanguard Total Stock Market Index Fund 0 166.27
XRS2.F Xtrackers Russell 2000 UCITS ETF 0.00616114 318.35
SC0K.DE Invesco Russell 2000 UCITS ETF 0.0005 113.88
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00023 165.56
RTYS.L Invesco Russell 2000 UCITS ETF 0.0005 135.35
XRSG.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.00616114 28721
XRSU.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.00616114 391.785
XRS2.DE Xtrackers Russell 2000 UCITS ETF 0.00616114 333.85
VTS.AX Vanguard US Total Market Shares Index ETF 0 481.52
VEMPX Vanguard Extended Market Index InstlPlus 0.00023 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 311.9
RSSL Global X Funds 0 103.93
Unlock